2016 Publications

• Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient. Kahn R, Garcia-Soto A, Silva-Smith R, Pinto A, George SH. Gynecol Oncol Rep. 2016 Aug;17:93-5. doi: 10.1016/j.gore.2016.08.001. eCollection 2016 Aug. PubMed PMID: 27547810; PubMed Central PMCID: PMC4983106.
• A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, Akbari MR, Ali J, Hurley J. Breast Cancer Res Treat. 2016 Aug;159(1):131-8. doi: 10.1007/s10549-016-3870-4. Epub 2016 Jul 28. PubMed PMID: 27469594.
• Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention. George SH, Garcia R, Slomovitz BM. Front Oncol. 2016;6:108. doi: 10.3389/fonc.2016.00108. eCollection 2016. Review. PubMed PMID: 27200296; PubMed Central PMCID: PMC4852190.
• Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. George SH, Milea A, Sowamber R, Chehade R, Tone A, Shaw PA. Oncogene. 2016 Jan 7;35(1):59-68. doi: 10.1038/onc.2015.62. Epub 2015 Mar 23. PubMed PMID: 25798842.